Cell delivery routes for stem cell therapy to the heart: Current and future approaches

Journal of Cardiovascular Translational Research

Volumn 5, Issue 5, 2012, Pages 713-726

  Campbell, Niall G ^a   Suzuki, Ken ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell based therapy; Heart; Intracoronary injection; Intramyocardial injection; Stem cell

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORODEOXYGLUCOSE F 18;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL FATE; CELL SURVIVAL; CELL TRANSFER; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEASIBILITY STUDY; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; IATROGENIC DISEASE; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL; NONHUMAN; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; ANIMAL; CONVALESCENCE; HEART CATHETERIZATION; HEART MUSCLE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE; REVIEW; TREATMENT OUTCOME;

ANIMALS; CARDIAC CATHETERIZATION; HEART DISEASES; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAMUSCULAR; MYOCARDIUM; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84874171310     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9378-3     Document Type: Article

References (110)

1. Siminiak, T.; Kalawski, R.; Fiszer, D.; Jerzykowska, O.; Rzezniczak, J.; Rozwadowska, N.; et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531-537.
2. Zhao, Q.; Sun, Y.; Xia, L.; Chen, A.; Wang, Z. (2008). Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. The Annals of Thoracic Surgery, 86(6), 1833-1840.
3. Dib, N.; Michler, R. E.; Pagani, F. D.; Wright, S.; Kereiakes, D. J.; Lengerich, R.; et al. (2005). Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Circulation, 112(12), 1748-1755. doi: 10.1161/circulationaha.105.547810.
4. Fukushima, S.; Coppen, S. R.; Lee, J.; Yamahara, K.; Felkin, L. E.; Terracciano, C. M. N.; et al. (2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS One, 3(8), e3071.
5. Losordo, D. W.; Schatz, R. A.; White, C. J.; Udelson, J. E.; Veereshwarayya, V.; Durgin, M.; et al. (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina. Circulation, 115(25), 3165-3172. doi: 10.1161/circulationaha.106.687376.
6. Brasselet, C.; Morichetti, M. C.; Messas, E.; Carrion, C.; Bissery, A.; Bruneval, P.; et al. (2005). Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. European Heart Journal, 26(15), 1551-1556. doi: 10.1093/eurheartj/ehi151.
7. Thompson, C. A.; Nasseri, B. A.; Makower, J.; Houser, S.; McGarry, M.; Lamson, T.; et al. (2003). Percutaneous transvenous cellular cardiomyoplasty - a novel nonsurgical approach for myocardial cell transplantation. Journal of the American College of Cardiology, 41(11), 1964-1971. doi: 10.1016/s0735-1097(03) 00397-8.
8. Ikeno, F.; Lyons, J.; Kaneda, H.; Baluom, M.; Benet, L. Z.; Rezaee, M. (2004). Novel percutaneous adventitial drug delivery system for regional vascular treatment. Catheterization and Cardiovascular Interventions, 63(2), 222-230.
9. Penn, M. S.; Ellis, S.; Gandhi, S.; Greenbaum, A.; Hodes, Z.; Mendelsohn, F. O.; et al. (2012). Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circulation Research, 110(2), 304-311.
10. Medicetty, S.; Wiktor, D.; Lehman, N.; Raber, A.; Popovic, Z. B.; Deans, R.; et al. (2012). Percutaneous adventitial delivery of allogeneic bone marrow derived stem cells via infarct related artery improves long-term ventricular function in acute myocardial infarction. Cell Transplant. doi: 10.3727/096368911x603657.
11. Hou, D.; Youssef, E. A.; Brinton, T. J.; Zhang, P.; Rogers, P.; Price, E. T.; et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation, 112(9 Suppl), I150-I156.
12. George, J. C.; Goldberg, J.; Joseph, M.; Abdulhameed, N.; Crist, J.; Das, H.; et al. (2008). Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. Journal of Interventional Cardiology, 21(5), 424-431.
13. Perin, E. C.; Silva, G. V.; Assad, J. A. R.; Vela, D.; Buja, L. M.; Sousa, A. L. S.; et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44(3), 486-495.
14. Suzuki, K.; Murtuza, B.; Beauchamp, J. R.; Brand, N. J.; Barton, P. J.; Varela-Carver, A.; et al. (2004). Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110(11 Suppl 1), II219-II224. doi: 10.1161/01.CIR.0000138388.55416. 06.
15. Suzuki, K.; Murtuza, B.; Beauchamp, J. R.; Smolenski, R. T.; Varela-Carver, A.; Fukushima, S.; et al. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. The FASEB Journal. doi: 10.1096/fj.03-1308fje. 03-1308fje.
16. ukushima, S.; Varela-Carver, A.; Coppen, S. R.; Yamahara, K.; Felkin, L. E.; Lee, J.; et al. (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation, 115(17), 2254-2261. doi: 10.1161/CIRCULATIONAHA.106.662577.
17. Veltman, C. E.; Soliman, O. I. I.; Geleijnse, M. L.; Vletter, W. B.; Smits, P. C.; ten Cate, F. J.; et al. (2008). Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. European Heart Journal, 29(11), 1386-1396. doi: 10.1093/eurheartj/ehn171.
18. Coppen, S. R.; Fukushima, S.; Shintani, Y.; Takahashi, K.; Varela-Carver, A.; Salem, H.; et al. (2008). A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation, 118(14 Suppl), S138-S144. doi: 10.1161/CIRCULATIONAHA.107.779629.
19. Menasche, P.; Alfieri, O.; Janssens, S.; McKenna, W.; Reichenspurner, H.; Trinquart, L.; et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation, 117(9), 1189-1200. doi: 10.1161/CIRCULATIONAHA.107.734103.
20. Donndorf, P.; Kundt, G.; Kaminski, A.; Yerebakan, C.; Liebold, A.; Steinhoff, G.; et al. (2011). Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, 142(4), 911-920.
21. Arom, K. V.; Ruengsakulrach, P.; Jotisakulratana, V. (2008). Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovascular and Thoracic Annals, 16(2), 143-148.
22. Ota, T.; Patronik, N. A.; Schwartzman, D.; Riviere, C. N.; Zenati, M. A. (2008). Minimally invasive epicardial injections using a novel semiautonomous robotic device. Circulation, 118(14 suppl 1), S115-S120. doi: 10.1161/circulationaha.107.756049.
23. Lee, W.-Y.; Wei, H.-J.; Lin, W.-W.; Yeh, Y.-C.; Hwang, S.-M.; Wang, J.-J.; et al. (2011). Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials, 32(24), 5558-5567.
24. Huang, N. F.; Yu, J.; Sievers, R.; Li, S.; Lee, R. J. (2005). Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Engineering, 11(11-12), 1860-1866.
25. Christman, K. L.; Vardanian, A. J.; Fang, Q.; Sievers, R. E.; Fok, H. H.; Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44(3), 654-660.
26. Nakamuta, J. S.; Danoviz, M. E.; Marques, F. L. N.; dos Santos, L.; Becker, C.; Goncalves, G. A.; et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One, 4(6), e6005.
27. Strauer, B. E.; Brehm, M.; Zeus, T.; Gattermann, N.; Hernandez, A.; Sorg, R. V.; et al. (2001). Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Deutsche Medizinische Wochenschrift, 126(34-35), 932-938.
28. Tuma, J.; Fernanadez-Vina, R.; Carrasco, A.; Castillo, J.; Cruz, C.; Carrillo, A.; et al. (2011). Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina. Journal of Translational Medicine, 9(1), 183. doi: 10.1186/1479-5876-9-183.
29. Moreira Rde, C.; Haddad, A. F.; Silva, S. A.; Souza, A. L.; Tuche, F. A.; Oliveira, M. A.; et al. (2011). Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study. Arquivos Brasileiros de Cardiologia, 97(5), 420-426.
30. Toma, C.; Pittenger, M. F.; Cahill, K. S.; Byrne, B. J.; Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1), 93-98. doi: 10.1161/hc0102. 101442.
31. Freyman, T.; Polin, G.; Osman, H.; Crary, J.; Lu, M.; Cheng, L.; et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27(9), 1114-1122.
32. Goussetis, E.; Manginas, A.; Koutelou, M.; Peristeri, I.; Theodosaki, M.; Kollaros, N.; et al. (2006). Intracoronary infusion of CD133 Selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells, 24(10), 2279-2283.
33. Fukushima, S.; Campbell, N. G.; Coppen, S. R.; Yamahara, K.; Yuen, A. H. Y.; Smolenski, R. T.; et al. (2011). Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. The Journal of Heart and Lung Transplantation, 30(2), 227-233. doi: 10.1016/j.healun.2010.09.002.
34. Doyle, B.; Kemp, B. J.; Chareonthaitawee, P.; Reed, C.; Schmeckpeper, J.; Sorajja, P.; et al. (2007). Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. Journal of Nuclear Medicine, 48(10), 1708-1714. doi: 10.2967/jnumed.107.042838.
35. Vulliet, P. R.; Greeley, M.; Halloran, S. M.; MacDonald, K. A.; Kittleson, M. D. (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet, 363(9411), 783-784. doi: 10.1016/S0140-6736(04)15695-X.
36. Schachinger, V.; Erbs, S.; Elsasser, A.; Haberbosch, W.; Hambrecht, R.; Holschermann, H.; et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1210-1221.
37. Assmus, B.; Rolf, A.; Erbs, S.; Elsasser, A.; Haberbosch, W.; Hambrecht, R.; et al. (2010). Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation. Heart Failure, 3(1), 89-96. doi: 10.1161/circheartfailure.108. 843243.
38. Clifford, D. M.; Fisher, S. A.; Brunskill, S. J.; Doree, C.; Mathur, A.; Watt, S.; et al. (2012). Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews, 2, CD006536.
39. Konstam, M. A.; Rousseau, M. F.; Kronenberg, M. W.; Udelson, J. E.; Melin, J.; Stewart, D.; et al. (1992). Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circulation, 86(2), 431-438.
40. Seth, S.; Bhargava, B.; Narang, R.; Ray, R.; Mohanty, S.; Gulati, G.; et al. (2010). The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) Trial: a long-term follow-up study. Journal of the American College of Cardiology, 55(15), 1643-1644.
41. Jaiswal, R. K.; Jaiswal, N.; Bruder, S. P.; Mbalaviele, G.; Marshak, D. R.; Pittenger, M. F. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. Journal of Biological Chemistry, 275(13), 9645-9652. doi: 10.1074/jbc.275.13.9645.
42. Bolli, R.; Chugh, A. R.; D'Amario, D.; Loughran, J. H.; Stoddard, M. F.; Ikram, S.; et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet, 378(9806), 1847-1857.
43. Makkar, R. R.; Smith, R. R.; Cheng, K.; Malliaras, K.; Thomson, L. E. J.; Berman, D.; et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet, 379(9819), 895-904.
44. Tossios, P.; Krausgrill, B.; Schmidt, M.; Fischer, T.; Halbach, M.; Fries, J. W.; et al. (2008). Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. European Heart Journal, 29(15), 1911-1921.
45. Yao, K.; Huang, R.; Sun, A.; Qian, J.; Liu, X.; Ge, L.; et al. (2009). Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. European Journal of Heart Failure, 11(7), 691-698. doi: 10.1093/eurjhf/hfp062.
46. Gu, X. A.; Xie, Y.; Gu, J. A.; Sun, L.; He, S. H.; Xu, R. X.; et al. (2011). Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure - a pilot study. Circulation Journal, 75(4), 955-963. doi: 10.1253/circj.CJ-10-0898.
47. Kang, H.-J.; Lee, H.-Y.; Na, S.-H.; Chang, S.-A.; Park, K.-W.; Kim, H.-K.; et al. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114(1-suppl), I-145-I-151. doi: 10.1161/circulationaha.105. 001107.
48. Pasha, Z.; Wang, Y.; Sheikh, R.; Zhang, D.; Zhao, T.; Ashraf, M. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77(1), 134-142. doi: 10.1093/cvr/cvm025.
49. Pons, J.; Huang, Y.; Arakawa-Hoyt, J.; Washko, D.; Takagawa, J.; Ye, J.; et al. (2008). VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochemical and Biophysical Research Communications, 376(2), 419-422.
50. Ryzhov, S.; Solenkova, N. V.; Goldstein, A. E.; Lamparter, M.; Fleenor, T.; Young, P. P.; et al. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circulation Research, 102(3), 356-363. doi: 10.1161/circresaha.107.158147.
51. Aicher, A.; Brenner, W.; Zuhayra, M.; Badorff, C.; Massoudi, S.; Assmus, B.; et al. (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation, 107(16), 2134-2139. doi: 10.1161/01.CIR.0000062649.63838.C9.
52. Forest, V. F.; Tirouvanziam, A. M.; Perigaud, C.; Fernandes, S.; Fusellier, M. S.; Desfontis, J. C.; et al. (2010). Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Research and Therapy, 1(1), 4. doi: 10.1186/scrt4.
53. Brenner, W.; Aicher, A.; Eckey, T.; Massoudi, S.; Zuhayra, M.; Koehl, U.; et al. (2004). 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. Journal of Nuclear Medicine, 45(3), 512-518.
54. Kang, W. J.; Kang, H. J.; Kim, H. S.; Chung, J. K.; Lee, M. C.; Lee, D. S. (2006). Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. Journal of Nuclear Medicine, 47(8), 1295-1301.
55. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277-2286.
56. Nagaya, N.; Fujii, T.; Iwase, T.; Ohgushi, H.; Itoh, T.; Uematsu, M.; et al. (2004). Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. American Journal of Physiology - Heart and Circulatory Physiology, 287(6), H2670-H2676. doi: 10.1152/ajpheart.01071.2003.
57. Kraitchman, D. L.; Tatsumi, M.; Gilson, W. D.; Ishimori, T.; Kedziorek, D.; Walczak, P.; et al. (2005). Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation, 112(10), 1451-1461. doi: 10.1161/CIRCULATIONAHA.105.537480.
58. Chiu, L. L.; Iyer, R. K.; Reis, L. A.; Nunes, S. S.; Radisic, M. (2012). Cardiac tissue engineering: current state and perspectives. Frontiers in Bioscience: a Journal and Virtual Library, 17, 1533-1550.
59. Elloumi-Hannachi, I.; Yamato, M.; Okano, T. (2010). Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. Journal of Internal Medicine, 267(1), 54-70.
60. Yang, J.; Yamato, M.; Kohno, C.; Nishimoto, A.; Sekine, H.; Fukai, F.; et al. (2005). Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials, 26(33), 6415-6422.
61. Sekine, H.; Shimizu, T.; Kosaka, S.; Kobayashi, E.; Okano, T. (2006). Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation, 25(3), 324-332.
62. Miyahara, Y.; Nagaya, N.; Kataoka, M.; Yanagawa, B.; Tanaka, K.; Hao, H.; et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12(4), 459-465.
63. Matsuura, K.; Honda, A.; Nagai, T.; Fukushima, N.; Iwanaga, K.; Tokunaga, M.; et al. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. The Journal of Clinical Investigation, 119(8), 2204-2217.
64. Bel, A.; Planat-Bernard, V.; Saito, A.; Bonnevie, L.; Bellamy, V.; Sabbah, L.; et al. (2010). Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation, 122(11 suppl 1), S118-S123. doi: 10.1161/ circulationaha.109.927293.
65. Memon, I. A.; Sawa, Y.; Fukushima, N.; Matsumiya, G.; Miyagawa, S.; Taketani, S.; et al. (2005). Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. The Journal of Thoracic and Cardiovascular Surgery, 130(5), 1333-1341.
66. Miyagawa, S.; Saito, A.; Sakaguchi, T.; Yoshikawa, Y.; Yamauchi, T.; Imanishi, Y.; et al. (2010). Impaired myocardium regeneration with skeletal cell sheets - a preclinical trial for tissue-engineered regeneration therapy. Transplantation, 90(4), 364-372. doi: 10.1097/TP.0b013e3181e6f201.
67. Yeo, C.; Mathur, A. (2009). Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regenerative Medicine, 4(1), 119-127.
68. Stamm, C.; Kleine, H.-D.; Choi, Y. H.; Dunkelmann, S.; Lauffs, J. A.; Lorenzen, B.; et al. (2007). Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. The Journal of Thoracic and Cardiovascular Surgery, 133(3), 717-725.
69. Patel, A. N.; Geffner, L.; Vina, R. F.; Saslavsky, J.; Urschel, H. C.; Kormos, R.; et al. (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. The Journal of Thoracic and Cardiovascular Surgery, 130(6), 1631-1638.
70. Mocini, D.; Staibano, M.; Mele, L.; Giannantoni, P.; Menichella, G.; Colivicchi, F.; et al. (2006). Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. American Heart Journal, 151(1), 192-197.
71. Hendrikx, M.; Hensen, K.; Clijsters, C.; Jongen, H.; Koninckx, R.; Bijnens, E.; et al. (2006). Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation. Circulation, 114(1 suppl), I-101-I-107. doi: 10.1161/circulationaha.105.000505.
72. Ang, K.-L.; Chin, D.; Leyva, F.; Foley, P.; Kubal, C.; Chalil, S.; et al. (2008). Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nature Clinical Practice. Cardiovascular Medicine, 5(10), 663-670.
73. Yerebakan, C.; Kaminski, A.; Westphal, B.; Donndorf, P.; Glass, A.; Liebold, A.; et al. (2011). Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133+ bone marrow stem cell transplant. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1530.e3-1539.e3.
74. Perin, E. C.; Dohmann, H. F. R.; Borojevic, R.; Silva, S. A.; Sousa, A. L. S.; Silva, G. V.; et al. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(11 suppl 1), II-213-II-218. doi: 10.1161/01.cir.0000138398.77550.62.
75. Beeres, S. L. M. A.; Bax, J. J.; Kaandorp, T. A. M.; Zeppenfeld, K.; Lamb, H. J.; Dibbets-Schneider, P.; et al. (2006). Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. The American Journal of Cardiology, 97(9), 1326-1331.
76. Fuchs, S.; Kornowski, R.; Weisz, G.; Satler, L. F.; Smits, P. C.; Okubagzi, P.; et al. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. The American Journal of Cardiology, 97(6), 823-829.
77. Dib, N.; Dinsmore, J.; Lababidi, Z.; White, B.; Moravec, S.; Campbell, A.; et al. (2009). One-year follow-up of feasibility and safety of the first us, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC Study). JACC. Cardiovascular Interventions, 2(1), 9-16. doi: 10.1016/j.jcin.2008.11.003.
78. Williams, A. R.; Trachtenberg, B.; Velazquez, D. L.; McNiece, I.; Altman, P.; Rouy, D.; et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy/novelty and significance. Circulation Research, 108(7), 792-796. doi: 10.1161/circresaha.111.242610.
79. Perin, E. C.; Silva, G. V.; Henry, T. D.; Cabreira-Hansen, M. G.; Moore, W. H.; Coulter, S. A.; et al. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161(6), 1078.e3-1087.e3.
80. Povsic, T. J.; O'Connor, C. M.; Henry, T.; Taussig, A.; Kereiakes, D. J.; Fortuin, F. D.; et al. (2011). A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. American Heart Journal, 162(4), 654.e1-662.e1.
81. Duckers, H. J.; Houtgraaf, J.; Hehrlein, C.; Schofer, J.; Waltenberger, J.; Gershlick, A.; et al. (2011). Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention, 6(7), 805-812. doi: 10.4244/eijv6i7a139.
82. Strauer, B. E.; Brehm, M.; Zeus, T.; Kostering, M.; Hernandez, A.; Sorg, R. V.; et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913-1918.
83. Schachinger, V.; Assmus, B.; Britten, M. B.; Honold, J.; Lehmann, R.; Teupe, C.; et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44(8), 1690-1699.
84. Chen, S. L.; Fang, W. W.; Ye, F.; Liu, Y. H.; Qian, J.; Shan, S. J.; et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94(1), 92-95.
85. Wollert, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141-148.
86. Ruan, W.; Pan, C. Z.; Huang, G. Q.; Li, Y. L.; Ge, J. B.; Shu, X. H. (2005). Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chinese Medical Journal, 118(14), 1175-1181.
87. Strauer, B. E.; Brehm, M.; Zeus, T.; Bartsch, T.; Schannwell, C.; Antke, C.; et al. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. Journal of the American College of Cardiology, 46(9), 1651-1658.
88. Ge, J.; Li, Y.; Qian, J.; Shi, J.; Wang, Q.; Niu, Y.; et al. (2006). Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart, 92(12), 1764-1767.
89. Janssens, S.; Dubois, C.; Bogaert, J.; Theunissen, K.; Deroose, C.; Desmet, W.; et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. The Lancet, 367(9505), 113-121.
90. Lunde, K.; Solheim, S.; Aakhus, S.; Arnesen, H.; Abdelnoor, M.; Egeland, T.; et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1199-1209.
91. Assmus, B.; Honold, J.; Schachinger, V.; Britten, M. B.; Fischer-Rasokat, U.; Lehmann, R.; et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine, 355(12), 1222-1232. doi: 10.1056/NEJMoa051779.
92. Penicka, M.; Horak, J.; Kobylka, P.; Pytlik, R.; Kozak, T.; Belohlavek, O.; et al. (2007). Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study. Journal of the American College of Cardiology, 49(24), 2373-2374.
93. Li, Z. Q.; Zhang, M.; Jing, Y. Z.; Zhang, W. W.; Liu, Y.; Cui, L. J.; et al. (2007). The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology, 115(1), 52-56.
94. Tatsumi, T.; Ashihara, E.; Yasui, T.; Matsunaga, S.; Kido, A.; Sasada, Y.; et al. (2007). Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circulation Journal, 71(8), 1199-1207.
95. Huikuri, H. V.; Kervinen, K.; Niemela, M.; Ylitalo, K.; Saily, M.; Koistinen, P.; et al. (2008). Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal, 29(22), 2273-2737.
96. Meluzin, J.; Janousek, S.; Mayer, J.; Groch, L.; Hornacek, I.; Hlinomaz, O.; et al. (2008). Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology, 128(2), 185-192.
97. Plewka, M.; Krzeminska-Pakula, M.; Peruga, J. Z.; Lipiec, P.; Kurpesa, M.; Wierzbowska-Drabik, K.; et al. (2009). The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results. Kardiologia Polska, 69(12), 1234-1240.
98. Cao, F.; Sun, D.; Li, C.; Narsinh, K.; Zhao, L.; Li, X.; et al. (2009). Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal, 30(16), 1986-1994.
99. Tendera, M.; Wojakowski, W.; Ruzyllo, W.; Chojnowska, L.; Kepka, C.; Tracz, W.; et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. European Heart Journal, 30(11), 1313-1321. doi: 10.1093/eurheartj/ehp073.
100. Yousef, M.; Schannwell, C. M.; Kostering, M.; Zeus, T.; Brehm, M.; Strauer, B. E. (2009). The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53(24), 2262-2269. doi: 10.1016/j.jacc.2009.02.051.
101. Grajek, S.; Popiel, M.; Gil, L.; Breborowicz, P.; Lesiak, M.; Czepczynski, R.; et al. (2010). Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. European Heart Journal, 31(6), 691-702.
102. Strauer, B.-E.; Yousef, M.; Schannwell, C. M. (2010). The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study. European Journal of Heart Failure, 12(7), 721-729. doi: 10.1093/eurjhf/hfq095.
103. Suarez de Lezo, J.; Herrera, C.; Pan, M.; Romero, M.; Pavlovic, D.; Segura, J.; et al. (2007). Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function. Revista Española de Cardiología, 60(4), 357-365.
104. Piepoli, M. F.; Vallisa, D.; Arbasi, M.; Cavanna, L.; Cerri, L.; Mori, M.; et al. (2010). Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). European Journal of Heart Failure, 12(2), 172-180. doi: 10.1093/eurjhf/hfp183.
105. Wohrle, J.; Merkle, N.; Mailander, V.; Nusser, T.; Schauwecker, P.; von Scheidt, F.; et al. (2010). Results of intracoronary stem cell therapy after acute myocardial infarction. The American Journal of Cardiology, 105(6), 804-812.
106. Hirsch, A.; Nijveldt, R.; van der Vleuten, P. A.; Tijssen, J. G. P.; van der Giessen, W. J.; Tio, R. A.; et al. (2011). Intracoronary infusion of
107. Roncalli, J.; Mouquet, F.; Piot, C.; Trochu, J.-N.; Le Corvoisier, P.; Neuder, Y.; et al. (2011). Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. European Heart Journal, 32(14), 1748-1757. doi: 10.1093/eurheartj/ehq455.
108. Traverse, J. H.; Henry, T. D.; Ellis, S. G.; Pepine, C. J.; Willerson, J. T.; Zhao, D. X. M.; et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function. JAMA: The Journal of the American Medical Association, 306(19), 2110-2119. doi: 10.1001/jama.2011.1670.
109. Quyyumi, A. A.; Waller, E. K.; Murrow, J.; Esteves, F.; Galt, J.; Oshinski, J.; et al. (2011). CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal, 161(1), 98-105.
110. Stamm et al. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. doi: 10.1016/S0140-6736(03)12110-1.